These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37168397)

  • 1. Frailty and subsequent adverse outcomes in older patients with atrial fibrillation treated with oral anticoagulants: The Shizuoka study.
    Nishimura S; Kumamaru H; Shoji S; Nakatani E; Yamamoto H; Ichihara N; Sandhu AT; Miyachi Y; Miyata H; Kohsaka S
    Res Pract Thromb Haemost; 2023 Mar; 7(3):100129. PubMed ID: 37168397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation.
    Kim D; Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
    Stroke; 2022 Jun; 53(6):1873-1882. PubMed ID: 35109686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation and oral anticoagulation in older people with frailty: a nationwide primary care electronic health records cohort study.
    Wilkinson C; Clegg A; Todd O; Rockwood K; Yadegarfar ME; Gale CP; Hall M
    Age Ageing; 2021 May; 50(3):772-779. PubMed ID: 33951158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the bleeding risk of anticoagulant treatment in non-severe frail octogenarians with atrial fibrillation.
    Shinohara M; Fujino T; Yao S; Yano K; Akitsu K; Koike H; Kinoshita T; Yuzawa H; Suzuki T; Kobayashi K; Ikeda T
    J Cardiol; 2019 Jan; 73(1):7-13. PubMed ID: 29898863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frailty, Cognitive Impairment, and Anticoagulation Among Older Adults with Nonvalvular Atrial Fibrillation.
    Mailhot T; McManus DD; Waring ME; Lessard D; Goldberg R; Bamgbade BA; Saczynski JS
    J Am Geriatr Soc; 2020 Dec; 68(12):2778-2786. PubMed ID: 32780497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the Appropriateness of Oral Anticoagulation for Atrial Fibrillation in Advanced Frailty: Use of Stroke and Bleeding Risk-Prediction Models.
    O'Caoimh R; Igras E; Ramesh A; Power B; O'Connor K; Liston R
    J Frailty Aging; 2017; 6(1):46-52. PubMed ID: 28244558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and Safety of Very-Low-Dose Edoxaban in Frail Patients With Atrial Fibrillation in the ELDERCARE-AF Randomized Clinical Trial.
    Akashi S; Oguri M; Ikeno E; Manita M; Taura J; Watanabe S; Hayashi T; Akao M; Okumura K; Akishita M; Yamashita T
    JAMA Netw Open; 2022 Aug; 5(8):e2228500. PubMed ID: 35997978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020.
    Ko D; Lin KJ; Bessette LG; Lee SB; Walkey AJ; Cheng S; Kim E; Glynn RJ; Kim DH
    JAMA Netw Open; 2022 Nov; 5(11):e2242964. PubMed ID: 36399339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
    Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
    Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):730-738. PubMed ID: 34694379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment patterns for oral anticoagulants in older patients with atrial fibrillation: a retrospective, cross-sectional, nationwide study from Denmark.
    Rasmussen PV; Sakthivel T; Dalgaard F; Gislason GH; Pallisgaard JL; Hansen ML
    BMJ Open; 2022 Sep; 12(9):e062353. PubMed ID: 36581981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.
    Lip GYH; Murphy RR; Sahiar F; Ingall TJ; Dhamane AD; Ferri M; Hlavacek P; Preib MT; Keshishian A; Russ C; Rosenblatt L; Yuce H; Deitelzweig S
    JAMA Netw Open; 2022 Aug; 5(8):e2229333. PubMed ID: 36044214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and impact of frailty in patients with atrial fibrillation in Europe.
    Proietti M; Romiti GF; Vitolo M; Harrison SL; Lane DA; Fauchier L; Marin F; Näbauer M; Potpara TS; Dan GA; Maggioni AP; Cesari M; Boriani G; Lip GYH;
    Age Ageing; 2022 Aug; 51(8):. PubMed ID: 35997262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea.
    Lee MY; Han S; Bang OY; On YK; Jang SW; Han S; Ryu J; Park YJ; Kang S; Suh HS; Kim YH
    Adv Ther; 2022 Jul; 39(7):3112-3130. PubMed ID: 35524839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of frailty models on the prescription of oral anticoagulants and on the incidence of stroke, bleeding, and mortality in older patients with atrial fibrillation: a systematic review.
    Presta R; Brunetti E; Polidori MC; Bo M
    Ageing Res Rev; 2022 Dec; 82():101761. PubMed ID: 36270605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geriatric Elements and Oral Anticoagulant Prescribing in Older Atrial Fibrillation Patients: SAGE-AF.
    Saczynski JS; Sanghai SR; Kiefe CI; Lessard D; Marino F; Waring ME; Parish D; Helm R; Sogade F; Goldberg R; Gurwitz J; Wang W; Mailhot T; Bamgbade B; Barton B; McManus DD
    J Am Geriatr Soc; 2020 Jan; 68(1):147-154. PubMed ID: 31574165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation.
    Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
    Clin Res Cardiol; 2022 Jan; 111(1):23-33. PubMed ID: 33704551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants: A Randomized Clinical Trial.
    Pokorney SD; Cocoros N; Al-Khalidi HR; Haynes K; Li S; Al-Khatib SM; Corrigan-Curay J; Driscoll MR; Garcia C; Calvert SB; Harkins T; Jin R; Knecht D; Levenson M; Lin ND; Martin D; McCall D; McMahill-Walraven C; Nair V; Parlett L; Petrone A; Temple R; Zhang R; Zhou Y; Platt R; Granger CB
    JAMA Netw Open; 2022 May; 5(5):e2214321. PubMed ID: 35639381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic and Bleeding Outcomes in Patients With Atrial Fibrillation and Contraindications to Oral Anticoagulation.
    Steinberg BA; Ballew NG; Greiner MA; Lippmann SJ; Curtis LH; O'Brien EC; Patel MR; Piccini JP
    JACC Clin Electrophysiol; 2019 Dec; 5(12):1384-1392. PubMed ID: 31857036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation.
    Madhavan M; Holmes DN; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Kowey PR; Mahaffey KW; Thomas L; Peterson ED; Chan P; Allen LA; Gersh BJ;
    Am Heart J; 2019 May; 211():77-89. PubMed ID: 30901602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF Study.
    Lefebvre MC; St-Onge M; Glazer-Cavanagh M; Bell L; Kha Nguyen JN; Viet-Quoc Nguyen P; Tannenbaum C
    Can J Cardiol; 2016 Feb; 32(2):169-76. PubMed ID: 26277091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.